Eribulin in Angiosarcoma and Epithelioid Hemangioendothelioma (EHE)
Clinical trial NCT03331250 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03331250
- Sponsor
- Massachusetts General Hospital
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-01-18
- Primary completion
- 2023-07-21
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.